CLINICAL_TRIALS
trial_result
· 2023-11-07
Clinical Trial Update: Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy Participants [Phase 1]
Summary
Phase 1 pharmacokinetic study of oral ALXN1840 in Japanese and non-Japanese healthy adults completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Wilson Disease | Phase 1 | Status: COMPLETED | Results posted: 2023-11-07